China is likely to seek more concessions from drugmakers

04/9/2013 | Bloomberg

The Chinese government is likely to seek pricing concessions from drugmakers on expensive cancer medicines and might resort to compulsory licensing in some cases, former health minister Chen Zhu said. Annual spending on health care in China is expected to reach $1 trillion by 2020, according to a McKinsey & Co. analysis.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA